Nektar Therapeutics priced an upsized $325 million public offering of 3,532,609 shares at $92.00 per share, expected to close April 23, 2026. 2 3 Underwriters have a 30-day option to purchase up to 529,891 additional shares. 2 3 Proceeds will fund general corporate purposes, including Phase 3 trials and manufacturing for rezpegaldesleukin in atopic dermatitis and alopecia areata. 2 6 No recent news found on Maze stock rises, Merck deal rumors, or BMS layoffs in provided results. Sources: 2. https://www.stocktitan.net/news/NKTR/nektar-therapeutics-announces-pricing-of-upsized-325-million-public-6zypsbvhu0q9.html 3. https://intellectia.ai/news/stock/nektar-therapeutics-prices-upsized-325m-public-offering 6. https://www.investing.com/news/company-news/nektar-prices-325m-stock-offering-at-92-per-share-93CH-4628008
- Get link
- X
- Other Apps